Vanda Pharmaceuticals, Inc.
(NASDAQ : VNDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -8.49%146.480.0%$1358.83m
NVAXNovavax, Inc. -12.39%74.1678.2%$509.11m
AMGNAmgen, Inc. -3.16%220.521.4%$496.54m
BIIBBiogen, Inc. -0.57%219.281.8%$493.98m
GILDGilead Sciences, Inc. -2.15%67.041.0%$481.47m
BNTXBioNTech SE -2.71%143.500.0%$402.29m
REGNRegeneron Pharmaceuticals, Inc. -2.25%607.412.7%$393.67m
ILMNIllumina, Inc. -3.44%353.353.3%$365.82m
VRTXVertex Pharmaceuticals, Inc. -1.42%224.851.9%$336.12m
SNSSSunesis Pharmaceuticals, Inc. -1.13%2.620.7%$183.15m
EXASEXACT Sciences Corp. -3.30%71.5917.9%$163.10m
ARNAArena Pharmaceuticals, Inc. -0.65%89.8913.7%$130.51m
INCYIncyte Corp. -1.36%73.772.4%$128.41m
ALNYAlnylam Pharmaceuticals, Inc. -2.60%132.878.2%$121.76m
BMRNBioMarin Pharmaceutical, Inc. -0.71%84.054.2%$102.45m

Company Profile

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.